Tumour diagnostic composition

Tumour diagnostic composition

  • CN 100,577,813 C
  • Filed: 03/29/2003
  • Issued: 01/06/2010
  • Est. Priority Date: 03/29/2002
  • Status: Active Grant
First Claim
Patent Images

1. a genome compound is used for diagnosing purposes in the test kit that the method for cancer that is selected from human prostata cancer, mammary cancer, colorectal carcinoma, lung cancer and ovarian cancer uses in preparation, gene in the described genome compound is Seq ID No.1-30, ID No.32, Seq ID No.34 and Seq ID No.98, described method comprises the otherness adjusting (with respect to the expression of same gene in normal population) of each gene in the identified gene composition.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×